Knowledge, perception and practice towards oxytocin stability and quality: A qualitative study of stakeholders in three resource-limited countries
Open Access
- 25 September 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (9) , e0203810
Abstract
Oxytocin is the gold standard drug for the prevention of postpartum haemorrhage, but limitations in cold chain systems in resource-constrained settings can severely compromise the quality of oxytocin product available in these environments. This study investigated the perspectives and practices of stakeholders in low and lower-middle income countries towards oxytocin, its storage requirements and associated barriers, and the quality of product available. Qualitative inquiries were undertaken in Ethiopia, India and Myanmar, where data was collected through Focus Group Discussions (FGDs) and In-Depth Interviews (IDIs). A total of 12 FGDs and 106 IDIs were conducted with 158 healthcare providers (pharmacists, midwives, nurses, doctors and obstetricians) and 40 key informants (supply chain experts, program managers and policy-makers). Direct observations of oxytocin storage practices and cold chain resources were conducted at 51 healthcare facilities. Verbatim transcripts of FGDs and IDIs were translated to English and analysed according to a thematic content analysis framework. Stakeholder awareness of oxytocin heat sensitivity and the requirement for cold storage of the drug was widespread in Ethiopia but more limited in Myanmar and India. A consistent finding across all study regions was the significant barriers to maintaining a consistent cold chain, with the lack of refrigeration facilities and unreliability of electricity cited as major challenges. Perceptions of compromised oxytocin quality were expressed by some stakeholders in each country. Knowledge of the heat sensitivity of oxytocin and the potential impacts of inconsistent cold storage on product quality is not widespread amongst healthcare providers, policy makers and supply chain experts in Myanmar, Ethiopia and India. Targeted training and advocacy messages are warranted to emphasise the importance of cold storage to maintain oxytocin quality.Keywords
Funding Information
- Saving Lives at Birth (AID-OAA-F-14-00046)
- Grand Challenges Canada (TTS 0609-05)
This publication has 18 references indexed in Scilit:
- The origins of the vaccine cold chain and a glimpse of the futureVaccine, 2017
- Quality of oxytocin available in low‐ and middle‐income countries: a systematic review of the literatureBJOG: An International Journal of Obstetrics & Gynaecology, 2016
- Use of prophylactic uterotonics during the third stage of labor: a survey of provider practices in community health facilities in Sierra LeoneBMC Pregnancy and Childbirth, 2016
- Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India.BMC Pregnancy and Childbirth, 2014
- Global causes of maternal death: a WHO systematic analysisThe Lancet Global Health, 2014
- Knowledge, Attitudes, and Practices Related to Uterotonic Drugs during Childbirth in Karnataka, India: A Qualitative Research StudyPLOS ONE, 2013
- Uterotonic drug quality: an assessment of the potency of injectable uterotonic drugs purchased by simulated clients in three districts in GhanaBMJ Open, 2012
- Active versus expectant management for women in the third stage of labour2011
- Health facility-based Active Management of the Third Stage of Labor: findings from a national survey in TanzaniaHealth Research Policy and Systems, 2009
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInternational Journal for Quality in Health Care, 2007